In Vitro, IL-10 Predominantly Influences the Production of Pro-Inflammatory Cytokines but Has Only Sporadic Effects on Co-Stimulatory Molecule Expression in Innate Immune Cells == We next aimed to understand effects of IL-10 around the functionality of individual immune cell subsets derived from donors with manifest lupus using in vitro culture

In Vitro, IL-10 Predominantly Influences the Production of Pro-Inflammatory Cytokines but Has Only Sporadic Effects on Co-Stimulatory Molecule Expression in Innate Immune Cells == We next aimed to understand effects of IL-10 around the functionality of individual immune cell subsets derived from donors with manifest lupus using in vitro culture. In vitro and in vivo effects of IL-10 were not fully concordant. In vivo IL-10R blockade slightly accelerated clinical lupus manifestations and immune dysregulation. Altogether, our side-by-side in vitro and in vivo comparison of the influence of IL-10 on different aspects of immunity shows that IL-10 has dual effects. Our results further reveal that the overall outcome may depend around the interplay of different factors such as target cell, inflammatory and stimulatory microenvironment, disease model and state. A comprehensive understanding of such influences is usually important to exploit IL-10 as a therapeutic target. Keywords:IL-10, systemic lupus erythematosus, IL-10R, autoimmunity == 1. Introduction == Interleukin (IL)-10 has emerged as a key mediator of the anti-inflammatory immune response. In the setting of infections, this is important to avoid an overwhelming immune response along with the appearance of tissue damage. In chronic inflammatory and autoimmune diseases as well as in cancerous conditions, IL-10 is usually involved in the regulation of the delicate balance between protective immunologic effector responses and the limitation of exaggerated inflammation as well as the maintenance of immune tolerance [1]. A failure of the latter leads to pathologic conditions, such Tanshinone IIA (Tanshinone B) as allergies and autoimmune diseases. Accordingly, for inflammatory bowel disease, clear beneficial effects of IL-10 are reported [2,3,4,5]. Protective, disease-mitigating influences of IL-10 through inhibition of inflammation and maintenance of self-tolerance are also reported for further immune-mediated diseases, such as psoriasis or rheumatoid arthritis, as well as allergic asthma [1,6,7,8]. In cancer, IL-10 can control tumor growth by potentiating the effects of anti-tumor CD8 T cells [9,10,11]. IL-10 is usually produced by various immune cells, including macrophages, monocytes, dendritic cells (DC), neutrophils, and CD4, CD8 T and B lymphocytes. Furthermore, IL-10 can target different cell types and exert an important regulatory role on both adaptive and innate immune responses [1,10,12]. The cellular response of IL-10 depends on its binding to the IL-10 receptor (IL-10R) and intracellular signaling cascades. Tanshinone IIA (Tanshinone B) The IL-10R is composed of two subunits, IL-10R1 and IL-10R2 chains [13]. IL-10R1 is mostly expressed on leukocytes and serves as a ligand binding subunit of the receptor complex. IL-10R2 is usually constitutively expressed in most cell types, shared by other cytokine receptors and required as an accessory chain for IL-10-induced signal transduction. IL-10R1 engagement induces its oligomerization with IL-10R2 followed by activation of JAK1 and TYK2, enabling the predominant recruitment and activation of the transcription factors STAT1, STAT3 and STAT5. In addition, other signaling cascades, such as PI3K, Akt or mTORC1, are reported to mediate IL-10 effects [14,15,16,17]. Due to their high IL-10R levels, monocytes and macrophages are considered the main Tanshinone IIA (Tanshinone B) targets. In many cases, inhibitory effects on these cells are reported. These comprise reduced pro-inflammatory cytokine production or down-regulation of co-stimulatory molecule expression [1,12,18,19,20,21]. IL-10 can also limit T cell responses, either by direct inhibitory effects or indirectly via its inhibitory function on antigen-presenting cells [22,23,24,25]. Further, IL-10 proved important in the maintenance of regulatory T cells (Treg) and their suppressive function [26,27]. In contrast to that, in CD8 T cells, IL-10 can increase their cytotoxic function, proliferation and interferon- (IFN-) production [28,29,30,31,32]. Such immune-stimulatory effects have also been reported for B cells as IL-10 could promote their survival, proliferation and differentiation [33,34,35,36]. Systemic lupus erythematosus (SLE) is usually a prototypical autoimmune disease of still not fully clarified etiology. Like in many other autoimmune diseases, a complex interplay of genetic and environmental factors contributes to the break of tolerance and immune dysregulation underlying disease pathology. Immune changes comprise both increased activation of autoreactive B and T cells and a dysregulated innate immune system, e.g., defective clearance of apoptotic material by phagocytes, increased IFN signature or presentation of nuclear antigen in a Tanshinone IIA (Tanshinone B) non-tolerogenic manner. This triggers the secretion of anti-nuclear or anti-double stranded DNA (-dsDNA) autoantibodies that can form immune complexes inducing organ inflammation and damage, e.g., in the kidney, joints, hematological compartment or the CNS [37,38,39]. The role of IL-10 in SLE remains insufficiently comprehended, and current data are controversial both in murine and human studies [39,40,41,42,43,44,45,46,47,48]. Specifically, Tanshinone IIA (Tanshinone B) stimulatory IL-10 effects on B cells and autoantibody production [49, 50] are suspected to be responsible for the often reported detrimental IL-10 effects on lupus pathology. Therefore, the aim of this study was to understand the regulation of IL-10 and IL-10R expression in the setting of lupus and their pro- versus anti-inflammatory effects on different Rabbit polyclonal to LRRC15 target immune cells in this context. The latter was explored in vitro and in vivo to understand the potential impact of IL-10 on individual immune cell functions in comparison to the complex in vivo setting. == 2. Results ==.